Substance / Medication

Arginine aspartate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

8 trials linked to this intervention

8
Total Trials
2
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Electrolyte and acid-base abnormalities associated with purging behaviors.
Mehler Philip S, Walsh Kristine · Int J Eat Disord · 2016
PMID: 26876281Meta-Analysis
Practical recommendations for coaches and athletes: a meta-analysis of sodium bicarbonate use for athletic performance.
Peart Daniel J, Siegler Jason C, Vince Rebecca V · J Strength Cond Res · 2012
PMID: 22505127Meta-Analysis
Effects of acute alkalosis and acidosis on performance: a meta-analysis.
Carr Amelia J, Hopkins Will G, Gore Christopher J · Sports Med · 2011
PMID: 21923200Meta-Analysis
Positive Effects of Pre-exercise Metabolic Alkalosis on Perceived Exertion and Post-exercise Squat Jump Performance in World-Class Cyclists.
Thomas Claire, Delfour-Peyrethon Rémi, Dorel Sylvain et al. · J Strength Cond Res · 2022
PMID: 33651728RCT
The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.
Blazejewski Sylvie, Georges Agnès, Forest Karelle et al. · Fundam Clin Pharmacol · 2009
PMID: 19527301Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Arginine aspartate (substance)
SNOMED CT
734646000
UMLS CUI
C0052327

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
8
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.